Meanwhile, homozygous Ctu2 mutation was identified in patients diagnosed with a novel multiple congenital anomalies syndrome called DREAM-PL which is characterized by dysmorphic facies, renal agenesis, ambiguous genitalia, microcephaly, and lissencephaly [11, 58]. The gene discussed is CTU2; the disease is lissencephaly spectrum disorders.